Read this and thought someone will be interested to know.
Masood Tayebi, Executive Chairman and Co-founder of BioDuro, a CRO headquartered in San Diego, broke down the growth in China’s CRO industry in distinct phases at the ChinaBio® Workshop “Leveraging China to Build a Global Biotech.”
• 2000-2004 – most of the work was low-cost outsourcing; the industry provided largely crank-turning commodity services;
• 2004-2007 – higher quality work, more protein drugs, DMPK, ADMET, basic pharmacology; influenced in part by growing numbers of returnees;
• Since 2007 – collaboration grows between client and CRO as risk sharing increases to modest levels; CROs contribute their innovative skills; and
• Future – CROs providing scientific breakthroughs for their clients.
